Skip to Content


Notice of Intent To Prepare an Environmental Impact Statement for the National Emerging Infectious Disease Laboratories Facility in Boston, MA

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


National Institutes of Health (NIH), DHHS.


Notice of intent to prepare an environmental impact statement for the National Emerging Infectious Diseases Laboratories facility in Boston, MA—extension of comment period and rescheduling of public meeting.


The Department of Health and Human Services (DHHS), National Institutes of Health (NIH), announced its intent to prepare an environmental impact statement (EIS) to evaluate a proposed new National Emerging Infectious Disease Laboratories facility in Boston, MA in the Federal Register on January 9, 2004. The Public Scoping meeting has been rescheduled to Start Printed Page 5994Tuesday, February 17th from 7 to 9 p.m. in Fanueil Hall, One Dock Square (corner of Congress and North Streets), Boston, MA 02109. The comment period on the scope of the EIS for the proposed project is extended to March 2, 2004. Comments should be received no later than March 2, 2004. All comments and questions should be directed to the address listed below.

Start Further Info


Valerie Nottingham, Chief, Environmental Quality Branch, Division of Environmental Protection, Office of Research Facilities, National Institutes of Health, DHHS, B13/2W64, Bethesda, MD 20892; by telephone 310-496-7775; fax 301-480-8056; or e-mail

Start Authority

Authority: 42 U.S.C. 4321-4341 (National Environmental Policy Act).

End Authority Start Signature

Dated: January 29, 2004.

Stephen A. Ficca,

Associate Director for Research Services, National Institutes of Health.

End Signature End Further Info End Preamble

[FR Doc. 04-2650 Filed 2-6-04; 8:45 am]